Hos patienter, der er behandlet med andre lægemidler, der sættes i forbindelse med levertoksicitet, anbefales monitorering af leverenzymer.
150 In patients treated with other medicinal products associated with liver toxicity, monitoring of liver enzymes is also recommended.